On this page
Pain Relief
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Acetaminophen | 650 mg/1 | 313782 | View |
Forms, strengths and routes
Source: NDC DirectoryRegulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 211544-001 | ACETAMINOPHEN | TABLET, EXTENDED RELEASE | ACETAMINOPHEN | Over-the-counter | — |
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 16 | Labeling | Approved | January 18, 2024 | Standard |
| Original application | 1 | Approved | April 16, 2019 | Standard |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251120). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingUse(s) • temporarily relieves minor aches and pains due to: • minor pain of arthritis • muscular aches • backache • premenstrual and menstrual cramps • the common cold • headache • toothache • temporarily reduces fever
Purpose
openFDA Drug LabelingPurpose Pain reliever/fever reducer
Dosage and Administration
openFDA Drug LabelingDirections do not take more than directed (see overdose warning ) adults and children 12 years and over take 2 caplets every 8 hours with water swallow whole; do not crush, chew, split or dissolve do not take more than 6 caplets in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years do not use
Warnings
openFDA Drug LabelingWarnings Liver warning: This product contains acetaminophen. Severe Liver damage may occur if you take • more than 6 caplets in 24 hours, which is the maximum daily amount • with other drugs containing acetaminophen • 3 or more alcoholic drinks everyday while using this product Allergy alert: acetaminophen may cause severe skin reactions Symptoms may include: • skin reddening • blisters • rash If a skin reaction occurs, stop use and seek medical help right away Do not use • with any other drugs containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. • if you are allergic to acetaminophen or any of the inactive ingredients in this product. Ask a doctor before use if you have liver disease Ask a doctor or pharmacist before use if taking the blood thinning drug warfarin. Stop use and ask a doctor if • pain gets worse or lasts more than 10 days • fever gets worse or lasts more than 3 days • new symptoms occur • redness or swelling is present These could be signs of a serious condition. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children Overdose warning: In case of overdose, get medical help or contact a poison control center right away.(1-800 222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms
Do Not Use
openFDA Drug LabelingDo not use • with any other drugs containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. • if you are allergic to acetaminophen or any of the inactive ingredients in this product.
Ask a Doctor
openFDA Drug LabelingAsk a doctor before use if you have liver disease
Stop Use
openFDA Drug LabelingStop use and ask a doctor if • pain gets worse or lasts more than 10 days • fever gets worse or lasts more than 3 days • new symptoms occur • redness or swelling is present These could be signs of a serious condition.
Active Ingredient
openFDA Drug LabelingActive ingredient (in each caplet) Acetaminophen 650 mg
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: ACETAMINOPHEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 69168-461-03 | 69168-461 | Allegiant Health | 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (69168-461-03) | May 24, 2024 |
| 69168-461-17 | 69168-461 | Allegiant Health | 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (69168-461-17) | November 18, 2024 |
| 69168-461-32 | 69168-461 | Allegiant Health | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69168-461-32) | May 24, 2024 |
| 42507-303-03 | 42507-303 | HYVEE INC | 1 BOTTLE, PLASTIC in 1 CARTON (42507-303-03) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC | November 20, 2025 |
| 69168-461 | 69168-461 | Allegiant Health | — | April 24, 2024 |
| 42507-303 | 42507-303 | HYVEE INC | — | November 20, 2025 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 10 sections on this page.